Live tape
Top 8, mentions 7d7,377SPCX1,446 mentions▲ +0.09GOOGL1,354 mentions▲ +0.05NVDA1,199 mentions▲ +0.09MSFT846 mentions▲ +0.04QQQ697 mentions▲ +0.08META640 mentions▲ +0.04SPY602 mentions▲ +0.06AMZN593 mentions▲ +0.07

Equity · Healthcare

COGT

NASDAQ

Cogent Biosciences, Inc.

$31 +3.33% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 9, 2026
Price · Chart
31 sessions
$45 $25 13 Jul 9 Oct

The line runs $37.48 on 13 July through $31 on 9 October, on a scale from $25 to $45. Days the market did not trade hold the previous close, flat.

Market cap $5.4B
52-week range $14 – $43
Avg volume 224.0K

as of Oct 9, 2026

COGT insider trades

SEC Form 4

COGT has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 October 2025.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Oct 2025 Ferrante Karen Jean Award 1,642

COGT reported financials

SEC EDGAR XBRL SEC EDGAR

COGT reported net income of −$328.9M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$328.9M 31 Dec 2025 fiscal year
Diluted EPS −$2.16 31 Dec 2025 fiscal year
Total assets $834.5M 30 Jun 2026 at period end
Total equity $532.4M 30 Jun 2026 at period end

COGT earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.52 —
31 Mar 2026 Q1 2026 −$0.53 —
31 Dec 2025 FY 2025 −$2.16 —
30 Sep 2025 Q3 2025 −$0.50 —
30 Jun 2025 Q2 2025 −$0.53 —
31 Mar 2025 Q1 2025 −$0.52 —
31 Dec 2024 FY 2024 −$1.94 —
30 Sep 2024 Q3 2024 −$0.52 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

COGT institutional holders

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a COGT position for the quarter ended 30 Jun 2026 — a combined $261.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Added +41.0% shares 996,168 $38.6M
Balyasny Asset Management Held (±25%) +11.5% shares 954,843 $37.0M
D. E. Shaw & Co. Trimmed −50.6% shares 922,479 $35.7M
Millennium Management Held (±25%) −23.9% shares 907,712 $35.1M
Citadel Advisors Trimmed −50.5% shares 849,694 $32.9M
Point72 Asset Management Trimmed −47.3% shares 744,195 $28.8M
Marshall Wace Trimmed −55.9% shares 706,153 $27.3M
AQR Capital Management Added +55.4% shares 294,913 $11.4M
Fisher Asset Management Held (±25%) +10.4% shares 184,875 $7.2M
Man Group Held (±25%) −13.8% shares 167,858 $6.5M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

COGT fails-to-deliver

SEC CNS data SEC

On 31 Aug 2026, 2,363 shares of COGT failed to deliver (about $82K) — the latest of at least 3 consecutive trading days with recorded fails. The run reaches the start of the window we read, so it may have begun earlier.

Settlement date Shares failed Notional % of shares out
31 Aug 2026 2,363 $82K 0.001%
28 Aug 2026 2,542 $94K 0.001%
27 Aug 2026 1,494 $55K 0.001%

Congressional trades in COGT

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in COGT is a purchase by Sara Jacobs (house, CA), dated 12 Dec 2022.

Date Member Type Amount
12 Dec 2022 filed 20 Jan 2023 Sara Jacobs house · Democrat–CA Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings